Prevention of Akute Kidney Injury, Hearttransplant, ANP

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2016
Prospective, blinded, placebo-controlled trial. Patients: Adult patients (\>18 years of age) undergoing de novo Htx, with a preoperative GFR \> 30ml/min, not receiving an ABO-incompatible organ with an ischemia time of \> 6 hours. A donor age \> 70 years is an exclusion criteria. Intervention: Infusion of h-ANP fore five days, starting at the induction of anesthesia. Outcome: Kidney function, evaluated with serum creatinine day 1-7 and kidney clearance, 4-5 Days after Htx plus after 3 and 12 months.
Epistemonikos ID: 2141122568a3dcd87b6ecf9c599202842673a8fc
First added on: May 12, 2024